Hydrogen is still a project business, and the stock trades like one


ITM makes money the hard way. It sells proton exchange membrane electrolyzers into a market that still depends on project finance, policy support, power prices and customer patience. That is why the stock does not trade like a boring industrial. It trades like a claim on future buildout, then gets repriced every time a project lands, a contract slips, or the hydrogen tape turns from hope to arithmetic.
The sector backdrop still matters because the whole category is trying to prove that green hydrogen can move from pilot language to repeatable revenue. Precedence Research put the green hydrogen market at roughly USD 12.31 billion in 2025 and USD 17.28 billion in 2026, while IDTechEx points to a much larger long-run market by 2037. Those are broad market numbers, and they do not tell you what ITM earns next quarter. They do tell you why every operating milestone matters, because the market is still pricing the path, not the destination.
ITM said on 4 August 2026 that it had made its first hydrogen delivery from the Lingen project to a customer. That matters because electrolyzer names live and die on proof of execution. A press release about ambition is cheap. A delivered molecule is harder to fake, and the market knows the difference.
The stock had some help from the wider tape too. UK equities were higher year to date, with the FTSE 100 near 10,775 to 10,811 in mid to late August, and AIM was moving in a relatively tight 792 to 801 range. In other words, the market was not handing out free passes, but it was not punishing growth stories indiscriminately either. Hydrogen names still had to earn their move.
That is where the peer set helps. Nel ASA was trading near 2.13 NOK after reporting Q2 2026 revenue of NOK 153 million, down 12% year over year, with backlog at NOK 1,213 million. Plug Power had just beaten Q2 2026 estimates, posted USD 178.3 million in revenue and lifted full-year 2026 revenue growth guidance to 15 to 16%, which gave the US side of the sector a burst of attention. Ballard Power kept showing sequential revenue growth in fuel-cell markets, but it remained a smaller-scale story. ITM sits in that same broad hydrogen bucket, but the market is reading it through project delivery and operating credibility, not through a simple peer multiple.
The share price on 21 August 2026 closed at 107.50 GBp. That is still a stock that asks for proof. It is also a stock that can move quickly when proof arrives, because the market is not paying for a mature annuity stream. It is paying for the next milestone, then the next one after that.
On 21 August 2026, ITM disclosed share transactions executed on 14 August 2026 under its Buy as You Earn Share Incentive Plan. Simon Bourne, the Chief Technology Officer, bought 136 ordinary shares at £1.103 each and received 136 matching shares from the company, for 272 shares in total. Chief Financial Officer Amy Grey bought 407 shares, reflecting three months of contributions, and received an equal match for 814 shares total. Chief Executive Officer Dennis Schulz bought 136 shares and received 136 matching shares, for 272 shares total.
The euro-normalised filing values were tiny, about EUR 350.84 for Bourne, EUR 1,049.94 for Grey and EUR 350.84 for Schulz. You do not need to pretend those are balance-sheet moves. They are not. But the structure matters. These were not random one-off buys from a single director trying to make a point. They were clustered, they came from the CEO, CFO and CTO, and they landed in the same disclosure window.
InsiderTrades data flags that as a cluster, and the score rationale is straightforward enough without turning it into a sermon. The buys came from an operating director set, they were part of multiple insiders trading the same name within a month, and the filing values were negligible relative to the company’s market value of EUR 866.3 million. That last point cuts both ways. Small size means you should not overread the cash amount. The fact that three senior executives were buying into the same plan at the same time is still a cleaner read than a lone token purchase.
The relevant historical bucket here is director-level buys at sweet-spot names, meaning companies in the EUR 300 million to EUR 1 billion market-cap band. InsiderTrades data shows 5,910 trades in that cohort, with a 52.8% 90-day win rate and a 3.47% average 90-day return. The 365-day average return in that bucket was 71.29%.
That is historical cohort data, not a forecast for ITM and not a promise that this filing will work. The bucket is useful because it tells you what has tended to happen when operating directors buy at mid-sized names where information is often less efficiently priced than at mega-caps. It does not tell you whether ITM will follow the average path. It tells you the kind of setup the market has historically been willing to reward more often than not.
The caveat matters because the numbers are not magic. A 52.8% win rate is barely above a coin flip if you strip away the context. The average 90-day return of 3.47% is modest. The 365-day figure is much larger, but longer windows are where a lot of things can happen that have nothing to do with the original filing. So treat the cohort as a lens, not a verdict. The filing still has to sit inside the company’s own operating story.

ITM is not a software company where insider buying can be read against recurring revenue and gross margin expansion. It is a capital-intensive hydrogen equipment name that needs project wins, delivery milestones and customer confidence to keep the story moving. That makes the operating cadence more visible and the market’s patience thinner. When a company like this gets a real delivery milestone, the filing that follows is easier to place.
The Lingen delivery gave the market a concrete event to anchor on. The director buys then arrived less than three weeks later. That sequence does not prove causality, and nobody should pretend it does. But it does line up with a management team that appears willing to buy into its own execution window rather than wait for a cleaner chart or a louder headline.
Analyst coverage still sits in the middle. Investors Chronicle data shows a moderate-buy consensus with 12-month targets ranging from 60 GBp to 200 GBp, with a median around 93.52 GBp in some aggregators. That spread tells you the market is still arguing with itself about how quickly ITM can convert project progress into durable economics. The insider cluster does not settle that argument. It does, however, tell you the boardroom is not acting as if the story has run out of road.
InsiderTrades data gives ITM a fundamental score of 15, with a rank of 27,474 out of 28,717. The underlying pillars in the dossier are not flattering. Quality is 9, and growth is not populated. That is a reminder that this is still a name where execution has to do the heavy lifting. A low fundamental score does not cancel an insider buy, but it does keep you honest about what kind of company this is.
The strategic framework behind the internal signal is also worth keeping in view, once. The live out-of-sample headline sits at 0.81, 26.4 and 51.5 on a restricted EU venue universe, and those figures do not survive search-aware deflation or a short single-regime window. That is a screen, not a promise. It helps explain why the cluster matters, but it should not be mistaken for a guarantee of anything on this name.
The practical point is simpler. ITM is still being judged on whether it can turn project milestones into a steadier commercial rhythm. The first Lingen delivery helps. The clustered director buys help a little more, because they show senior management putting fresh money into the same period of execution. But the company still has to keep shipping, keep signing, and keep proving that hydrogen is more than a headline trade.
The bullish case from here is not complicated. More delivery milestones, more evidence that project execution is repeatable, and more signs that the market is willing to pay for hydrogen infrastructure rather than just talk about it. If ITM keeps turning project announcements into physical deliveries, the stock can keep attracting attention even in a choppy AIM market.
The risk is equally plain. Hydrogen remains a sector where policy, power costs and customer timing can change the math quickly. Peer results show that even names with revenue can still be fighting for scale and backlog quality. Nel’s Q2 revenue decline is a reminder that the category is not moving in a straight line. Plug’s better quarter shows how quickly sentiment can swing when numbers improve. ITM sits between those poles, and the market will keep forcing it to prove which side it belongs on.
The insider filing does not erase that risk. It does something narrower and more useful. It tells you that the CEO, CFO and CTO bought into the same window, after a real operating milestone, in a company whose market value is still under EUR 1 billion. That is enough to matter. It is not enough to settle the stock. The next concrete thing to watch is whether ITM can turn the Lingen delivery into a sequence, not a one-off.
The filing itself came from Investegate’s RNS report on 21 August 2026, covering transactions executed on 14 August 2026 under the Buy as You Earn Share Incentive Plan. ITM’s investor page and LSE company page provide the company context, while Yahoo Finance supplied the closing price on 21 August 2026. Peer and sector context came from Nel’s Q2 2026 release, Barron’s coverage of Plug Power’s Q2 2026 results, and the green hydrogen market research cited above.
The point of the source stack is simple. The filing is real, the delivery milestone is real, and the peer backdrop is real. The rest is judgment, and judgment should stay attached to the facts.
This is not investment advice.
Dig deeper: ITM Power plc's full insider filing history.
This is not investment advice.
Attendo’s CFO bought and sold about EUR 381k each on August 31 as the care operator trades near 120.90 SEK after a stron...
Aurizon directors bought again as coal, bulk and buybacks reset the rail story. Here is how the filings stack up against...
Credit Corp directors bought into August weakness after record FY26 profit. The cluster helps, but US debt-buying condit...
M&S directors bought 77 shares via the SIP as UK retail stays soft. Here is what the filing adds, and where the case sti...
Vimian’s CEO and two executives bought on 29 August. Read the cluster against animal health, Swedish rates, and peer val...
Raiffeisen CEO Michael Höllerer bought 483 shares for EUR 30,090.90 as European banks trade on higher rates, lending gro...